STOCK WATCH
Sanjivani Parenterals Ltd (Rs.50.80), a small contract manufacturing company specialising in injectibles for the institutional and hospital segment. Its key clientele include Ranbaxy, Zydus Cadila, Alkem, Macleods, Ipca, Intas, Glenmark, Medley and Shreya Lifesciences among others. It is planning to launch half dozen of new injectibles and has filed dossiers for Capreomycin, an anti-TB drug. For FY05, it may report an EPS of Rs.6, which is expected to double in FY06. A strong buy at the current level.
Ador Fontech (Rs.63.80), an associate of Ador Welding, offers products and solutions for reclamation welding and recycling of vital machinery components. Its product basket includes filler wires, welding equipment/accessories, wire feeders, wear plates and cladded pipes. For FY05, it may declare 30% dividend, which offers a good dividend yield at CMP. For FY05 & FY06, it can report an EPS of Rs6 and Rs.9 respectively. Its share price can rise by 50% in the coming 12 months.
Aarti Drugs (Rs.144.35) is a fully integrated research-driven company developing processes for active pharma ingredients (APIs) & intermediates and provides turnkey solutions to the pharmaceutical industry. Its products are exported to more than 65 countries worldwide. It also manufactures vitamins, anti-asthma, anti-HIV, anti-arthritis, anti-fungal, antibiotics, ACE inhibitors, anti-osteoporosis, anti-diabetic, anti-cholinergic, sedatives and anti-depressant drugs at its manufacturing facilities situated at Tarapur and Sarigam. For FY05, it can report an EPS of Rs14 and Rs18 in FY06. A strong buy in the growing pharma sector.
BDH Industries (Rs.16.10) is a small but emerging player in the bulk drug and formulations business industry. It is recognised as one of India's leading manufacturers of therapeutic formulations covering wide range of pharmaceuticals. It exports a wide range of bulk drugs and formulations to leading organizations in more than 60 countries including Belgium, Chile, Costa Rica, Denmark, Dominican Republic, Germany, Kenya, Malaysia, Mauritius, Netherlands, Singapore, Sri Lanka, West Indies, etc. It is currently concentrating on anti-cancer injectibles and tablets, which will drive its future growth. With an expected EPS of more than Rs3 for FY06 and a current book value of Rs26, its share price can easily double in the next 15 months.
Ador Fontech (Rs.63.80), an associate of Ador Welding, offers products and solutions for reclamation welding and recycling of vital machinery components. Its product basket includes filler wires, welding equipment/accessories, wire feeders, wear plates and cladded pipes. For FY05, it may declare 30% dividend, which offers a good dividend yield at CMP. For FY05 & FY06, it can report an EPS of Rs6 and Rs.9 respectively. Its share price can rise by 50% in the coming 12 months.
Aarti Drugs (Rs.144.35) is a fully integrated research-driven company developing processes for active pharma ingredients (APIs) & intermediates and provides turnkey solutions to the pharmaceutical industry. Its products are exported to more than 65 countries worldwide. It also manufactures vitamins, anti-asthma, anti-HIV, anti-arthritis, anti-fungal, antibiotics, ACE inhibitors, anti-osteoporosis, anti-diabetic, anti-cholinergic, sedatives and anti-depressant drugs at its manufacturing facilities situated at Tarapur and Sarigam. For FY05, it can report an EPS of Rs14 and Rs18 in FY06. A strong buy in the growing pharma sector.
BDH Industries (Rs.16.10) is a small but emerging player in the bulk drug and formulations business industry. It is recognised as one of India's leading manufacturers of therapeutic formulations covering wide range of pharmaceuticals. It exports a wide range of bulk drugs and formulations to leading organizations in more than 60 countries including Belgium, Chile, Costa Rica, Denmark, Dominican Republic, Germany, Kenya, Malaysia, Mauritius, Netherlands, Singapore, Sri Lanka, West Indies, etc. It is currently concentrating on anti-cancer injectibles and tablets, which will drive its future growth. With an expected EPS of more than Rs3 for FY06 and a current book value of Rs26, its share price can easily double in the next 15 months.
Raj Rayon (Rs.35.25) is exclusively engaged in manufacturing of Polyester Texturised Yarn (PTY) and has three factories at Silvassa with a capacity to produce 25500 MTA of PTY. It is going for backward integration to produce 60000 MTA of partially oriented yarn (POY), which is the key raw material. For FY05, it may report an EPS of Rs.7. With the company planning a public issue in future, its share price can rise smartly in the short term. At the same time, it is not recommended for the long term since its equity will get diluted sharply after the public issue.
No comments:
Post a Comment